Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Mika, Hosokawa"'
Autor:
Yusuke Kono, Renpei Kamino, Soma Hirabayashi, Takuya Kishimoto, Himi Kanbara, Saki Danjo, Mika Hosokawa, Ken-ichi Ogawara
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 558 (2023)
Mesenchymal stem cells (MSCs) have a tumor-homing capacity; therefore, MSCs are a promising drug delivery carrier for cancer therapy. To maintain the viability and activity of MSCs, anti-cancer drugs are preferably loaded on the surface of MSCs, rath
Externí odkaz:
https://doaj.org/article/e8d123c0af4e427bb425892477491c53
Autor:
Shota Tanaka, Mika Hosokawa, Takumi Miyamoto, Aiko Nakagawa, Mika Haruna, Kumiko Ueda, Seigo Iwakawa, Ken-ichi Ogawara
Publikováno v:
Biochemistry and Biophysics Reports, Vol 26, Iss , Pp 100996- (2021)
microRNAs (miRNAs) contained in small extracellular vesicles (sEVs) are candidates for non-invasive biomarkers. Oxaliplatin (L-OHP) has been approved for advanced colorectal cancer (CRC) chemotherapy. However, the response to L-OHP differs among CRC
Externí odkaz:
https://doaj.org/article/0628385de8e242989e0303c525fd387d
Autor:
Mika Hosokawa, Keisuke Nagamine, Hiroshi Aochi, Kotarosumitomo Nakayama, Mikiko Sakuragi, Tamayo Morikawa, Mayumi Nakao, Tomoko Kiyokawa, Hisashi Kato, Yoshiaki Tomiyama, Hirokazu Kashiwagi
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 68:412-421
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c4c0fbe40364b1e5357bf2e898f72a0
https://doi.org/10.3925/jjtc.68.412
https://doi.org/10.3925/jjtc.68.412
Autor:
Mayumi Nakao, Hiroshi Aochi, Kotarosumitomo Nakayama, Mika Hosokawa, Mikiko Sakuragi, Tamayo Morikawa, Tomoko Kiyokawa, Keisuke Nagamine, Hisashi Kato, Hirokazu Kashiwagi, Yoshiaki Tomiyama
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 68:28-33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f24d47dfc4248b3624b3e8e13241a2e8
https://doi.org/10.3925/jjtc.68.28
https://doi.org/10.3925/jjtc.68.28
Autor:
Tomoko Kiyokawa, Kazuya Mimura, Keisuke Nagamine, Kotarosumitomo Nakayama, Mikiko Horiuchi, Tamayo Morikawa, Mika Hosokawa, Mayumi Nakao, Masayuki Endo, Tadashi Kimura, Hisashi Kato, Yoshiaki Tomiyama, Hirokazu Kashiwagi
Publikováno v:
International Journal of Hematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63421d93d89a3cba4aef62624b42ec57
https://doi.org/10.1007/s12185-023-03559-1
https://doi.org/10.1007/s12185-023-03559-1
Autor:
Yusuke Kono, Renpei Kamino, Soma Hirabayash, Takuya Kishimoto, Mika Hosokawa, Ken-ichi Ogawara
Mesenchymal stem cells (MSCs) have the tumor-homing capacity, and therefore MSCs are considered to be a promising drug delivery carrier for cancer therapy. To maintain the viability and activity of MSCs, anti-cancer drugs are preferably modified on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97ff1e6fc94f2aa715d5fda4c50353a7
Publikováno v:
Biochemical and Biophysical Research Communications. 578:157-162
Decitabine (DAC), a DNA methyltransferase (DNMT) inhibitor is a novel anti-cancer drug regulating epigenetic mechanisms. Similar to conventional anti-cancer drugs, drug resistance to DAC also has been reported, resulting in tumor recurrence. Our prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab51794025123e4ffb8d17ca03d64b9a
https://doi.org/10.1016/j.bbrc.2021.09.041
https://doi.org/10.1016/j.bbrc.2021.09.041
Publikováno v:
Biochemical and biophysical research communications. 607
Vorinostat (suberoylanilide hydroxamic acid: SAHA), a histone deacetylase inhibitor, has potential benefit of improving the resistance to conventional other anti-cancer drugs. This study was aimed to clarify whether SAHA improves the resistance to ox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::752b4d2ffc299a1e15232d67620e5c81
https://pubmed.ncbi.nlm.nih.gov/35358872
https://pubmed.ncbi.nlm.nih.gov/35358872
Autor:
Hiroshi Aochi, Mika Hosokawa, Tomoko Kiyokawa, Mayumi Nakao, Tamayo Morikawa, Yoshiaki Tomiyama, Keisuke Nagamine, Kotarosumitomo Nakayama, Mikiko Sakuragi
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 66:577-582
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::979aefd7d0d8b57f3c465633982dea9f
https://doi.org/10.3925/jjtc.66.577
https://doi.org/10.3925/jjtc.66.577
Publikováno v:
Drug Metabolism and Pharmacokinetics. 35:124-130
Decitabine (DAC), a DNA methylation inhibitor, is transported into cancer cells mainly via equilibrative nucleoside transporter 1 (ENT1) and subsequently phosphorylated by deoxycytidine kinase (dCK). We previously reported that apparent DAC uptake in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1aed95c3e8badd06a6701ff51a2975f
https://doi.org/10.1016/j.dmpk.2019.10.002
https://doi.org/10.1016/j.dmpk.2019.10.002